BofA/Merrill Lynch Upgrades ResMed (RMD) to Buy

September 29, 2016 9:56 AM EDT
Get Alerts RMD Hot Sheet
Price: $63.72 --0%

Rating Summary:
    6 Buy, 8 Hold, 4 Sell

Rating Trend: Down Down

Today's Overall Ratings:
    Up: 22 | Down: 27 | New: 31
Trade RMD Now!
Join SI Premium – FREE

Get instant alerts when news breaks on your stocks. Claim your 2-week free trial to StreetInsider Premium here.

BofA/Merrill Lynch upgraded ResMed (NYSE: RMD) from Neutral to Buy.

For an analyst ratings summary and ratings history on ResMed click here. For more ratings news on ResMed click here.

Shares of ResMed closed at $64.74 yesterday.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Related Entities

Merrill Lynch, Bank of America

Add Your Comment